UNIGE document Scientific Article
previous document  unige:29310  next document
add to browser collection
Title

STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in Rosiglitazone-treated mice

Authors
Szanto, Ildiko
Published in Scientific Reports. 2013, vol. 3, p. 2350
Abstract STAT6 interacts with PPARγ to elicit macrophage polarization towards an anti-inflammatory, insulin-sensitizing phenotype. Mice deficient in STAT6 display liver lipid accumulation (hepatosteatosis). Rosiglitazone (RSG), a PPARγ agonist, ameliorates hepatosteatosis and enhances insulin sensitivity. To elucidate the role of STAT6 in PPARγ action on hepatosteatosis we compared liver proteomes of RSG-treated wild type and STAT6-deficient mice and we identified pyruvate kinase M2 (PKM2), a glycolysis and proliferation-regulating enzyme that displayed STAT6-dependent expression. RSG induced PKM2 within inflammatory cells in liver but suppressed its expression in adipose tissue. RSG diminished hepatosteatosis and oxidative stress, enhanced fat accumulation and improved insulin sensitivity in STAT6-deficient mice. Our data reveal a complex interaction between STAT6 and PPARγ in the regulation of liver and adipose tissue lipid depot distribution and design STAT6 as a novel link between inflammatory cell metabolism and adipocyte and hepatocyte function.
Identifiers
PMID: 23917405
Full text
Article (Author postprint) (4 MB) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research groups Etudes et traitement de l'hépatite C et B (554)
Chimie et protéomique clinique (270)
Stress oxydatif et insuline (795)
Citation
(ISO format)
SAJIC, Tatjana et al. STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in Rosiglitazone-treated mice. In: Scientific Reports, 2013, vol. 3, p. 2350. https://archive-ouverte.unige.ch/unige:29310

203 hits

2 downloads

Update

Deposited on : 2013-08-14

Export document
Format :
Citation style :